Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)Release Date:Education Oncology USA BOOST - Multiple Myeloma An Oncology Boosting ProgramRelease Date:Quality Improvement Oncology Netherlands PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscapeRelease Date:Education Oncology All Education in the Era of Emerging Hemophilia TherapyRelease Date:Partner: National Bleeding Disorders FoundationEducation Rare Disease Guam, Puerto Rico, USA Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUCRelease Date:Education Oncology USA USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the FutureRelease Date:Education Hospital USA COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and TaiwanRelease Date:Education Vaccines All Menopause Hormone Therapy: Evidence-Based Recommendations and PracticesRelease Date:Education Internal Medicine USA Global Call for Collaborators – Pfizer Migraine ResearchRelease Date:Research Internal Medicine All Improving care in headache medicine and the management of migraineRelease Date:Quality Improvement Internal Medicine Israel The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)Release Date:Research Oncology China Elevating IBD Management Standards Through Targeted EducationRelease Date:Education Inflammation & Immunology Turkey